SE8803713D0 - Biologically active lipoprotein and its use - Google Patents
Biologically active lipoprotein and its useInfo
- Publication number
- SE8803713D0 SE8803713D0 SE19888803713A SE8803713A SE8803713D0 SE 8803713 D0 SE8803713 D0 SE 8803713D0 SE 19888803713 A SE19888803713 A SE 19888803713A SE 8803713 A SE8803713 A SE 8803713A SE 8803713 D0 SE8803713 D0 SE 8803713D0
- Authority
- SE
- Sweden
- Prior art keywords
- lipoprotein
- pharmaceutical composition
- biologically active
- patient
- active lipoprotein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19888803713A SE8803713D0 (sv) | 1988-10-18 | 1988-10-18 | Biologically active lipoprotein and its use |
DE68904530T DE68904530T3 (de) | 1988-10-18 | 1989-10-11 | Biologisch wirksames Lipoprotein und seine Verwendung. |
EP89850346A EP0368823B2 (en) | 1988-10-18 | 1989-10-11 | Biologically active lipoprotein and its use |
AT89850346T ATE84799T1 (de) | 1988-10-18 | 1989-10-11 | Biologisch wirksames lipoprotein und seine verwendung. |
JP1268838A JP2963923B2 (ja) | 1988-10-18 | 1989-10-16 | 生物学的に活性なリポタンパク質およびその使用 |
CA002000893A CA2000893C (en) | 1988-10-18 | 1989-10-17 | Biologically active lipoprotein and its use |
AU42996/89A AU623180B2 (en) | 1988-10-18 | 1989-10-17 | Biologicaly active lipoprotein and its use |
US07/423,346 US5223481A (en) | 1988-10-18 | 1989-10-18 | Biologically active lipoprotein and its use |
US08/064,382 US5455227A (en) | 1988-10-18 | 1993-05-21 | Biologically active lipoprotein and its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19888803713A SE8803713D0 (sv) | 1988-10-18 | 1988-10-18 | Biologically active lipoprotein and its use |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8803713D0 true SE8803713D0 (sv) | 1988-10-18 |
SE8803713A SE8803713A (sv) | 1988-10-18 |
Family
ID=20373667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE19888803713A SE8803713D0 (sv) | 1988-10-18 | 1988-10-18 | Biologically active lipoprotein and its use |
Country Status (8)
Country | Link |
---|---|
US (2) | US5223481A (sv) |
EP (1) | EP0368823B2 (sv) |
JP (1) | JP2963923B2 (sv) |
AT (1) | ATE84799T1 (sv) |
AU (1) | AU623180B2 (sv) |
CA (1) | CA2000893C (sv) |
DE (1) | DE68904530T3 (sv) |
SE (1) | SE8803713D0 (sv) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0329794B1 (en) * | 1987-09-01 | 1994-03-30 | Teijin Limited | Method for assaying human lung surface active substance |
SE8803713D0 (sv) * | 1988-10-18 | 1988-10-18 | Kabigen Ab | Biologically active lipoprotein and its use |
CA2063273C (en) * | 1989-07-11 | 2002-09-24 | Bradley J. Benson | Surfactant compositions and methods |
AU638474B2 (en) * | 1989-07-11 | 1993-07-01 | Genentech Inc. | Surfactant compositions and methods |
DE69125750D1 (de) * | 1990-05-21 | 1997-05-28 | Abbott Lab | Fettsäure-Oberflächenaktives-Lungenprotein Konjate |
US5258496A (en) * | 1990-07-10 | 1993-11-02 | Scios Nova Inc. | Isolation and purification of lung surfactant protein |
US5272252A (en) * | 1991-11-04 | 1993-12-21 | Merrell Dow Pharmaceuticals Inc. | Synthetic lung surfactant having antioxidant properties |
JP3961029B2 (ja) * | 1992-06-24 | 2007-08-15 | 博 木戸 | インフルエンザウィルス感染防止剤 |
DK0733645T3 (da) * | 1993-12-08 | 2003-07-14 | Mitsubishi Pharma Corp | Syntetisk peptid, lungeoverfladeaktivt stof indeholdende dette og præparat mod respiratory distress syndrome |
DE4418936A1 (de) * | 1994-05-31 | 1996-02-08 | Byk Gulden Lomberg Chem Fab | Polypeptid |
FR2739860B1 (fr) * | 1995-10-17 | 1998-01-02 | Coletica | Complexes amphiphiles, procede pour leur preparation et compositions en renfermant |
EP0904295B1 (en) * | 1996-05-15 | 2005-08-10 | ALTANA Pharma AG | Process for separating and analyzing hydrophobic proteins using thin layer chromatography |
US6476191B1 (en) * | 1999-02-05 | 2002-11-05 | Mixture Sciences, Inc. | Volatilizable solid phase supports for compound synthesis |
IT1308180B1 (it) * | 1999-02-12 | 2001-12-07 | Chiesi Farma Spa | Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante |
CA2384861A1 (en) | 1999-09-16 | 2001-03-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
DE50214446D1 (de) | 2001-10-11 | 2010-07-01 | Nycomed Gmbh | Neue verwendung von lungensurfactant |
WO2006013183A1 (en) | 2004-08-06 | 2006-02-09 | Altana Pharma Ag | Composition comprising a pulmonary surfactant and a tnf-derived peptide |
US7582312B2 (en) * | 2004-11-15 | 2009-09-01 | Discovery Laboratories, Inc. | Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
US7464012B2 (en) * | 2004-12-10 | 2008-12-09 | L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude | Simplified process simulator |
AU2006203978B2 (en) | 2005-01-06 | 2011-11-03 | Discovery Laboratories, Inc. | Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia |
JP2007309695A (ja) * | 2006-05-16 | 2007-11-29 | Univ Of Tokyo | 質量分析のための脂質修飾ペプチドの抽出方法 |
MX2009003002A (es) * | 2006-09-19 | 2009-06-01 | Discovery Lab Inc | Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco. |
US7951781B2 (en) | 2006-11-02 | 2011-05-31 | University Of Iowa Research Foundation | Methods and compositions related to PLUNC surfactant polypeptides |
ES2562806T3 (es) * | 2007-06-05 | 2016-03-08 | Paka Pulmonary Pharmaceuticals, Inc. | Composiciones para administrar medicamentos en los pulmones, y usos de las mismas |
CN102271666A (zh) | 2008-12-10 | 2011-12-07 | Paka肺部医药公司 | 用于向肺脏递送药物的方法和组合物 |
WO2013188016A2 (en) | 2012-05-04 | 2013-12-19 | Discovery Laboratories, Inc. | Surfactant therapy for exposure to ionizing radiation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4234475A (en) * | 1975-08-15 | 1980-11-18 | The Gillette Company | Reacting protein with organic acid |
DE2925942A1 (de) * | 1979-06-27 | 1981-01-22 | Bayer Ag | Disazokupferkomplex-reaktivfarbstoffe |
US4406833A (en) * | 1982-06-04 | 1983-09-27 | Fats And Proteins Research Foundation, Inc. | Surfactants derived from fatty acid esters and proteinaceous material |
US4659805A (en) * | 1984-12-11 | 1987-04-21 | California Biotechnology, Inc. | Recombinant alveolar surfactant protein |
US4933280A (en) * | 1984-12-11 | 1990-06-12 | California Biotechnology Inc. | Recombinant DNA sequence encoding Alveolar Surfactant Protein |
US4918161A (en) * | 1985-09-26 | 1990-04-17 | Genetics Institute, Inc. | Low molecular weight pulmonary surfactant proteins |
US4882422A (en) * | 1985-10-24 | 1989-11-21 | Genetics Institute, Inc. | Pulmonary surfactant proteins |
EP0273916A4 (en) * | 1986-05-06 | 1989-11-30 | Childrens Hosp Medical Center | LUNG HYDROPHOBES, PROTEIN ASSOCIATED TO A SURFACE ACTIVE MEDIUM OF 6000 DALTON MOLECULAR WEIGHT AND MULTIMEREOUS ITEMS. |
US5013720A (en) * | 1986-05-06 | 1991-05-07 | Abbott Laboratories | SAP-6-Val proteins and methods |
EP0290516A4 (en) * | 1986-10-24 | 1989-11-14 | Jeffrey A Whitsett | PROTEINS RELATED TO SURFACE-EFFECTIVE HYDROPHOBIC LUNG ACTIVE SUBSTANCES. |
JPH01501282A (ja) * | 1986-12-08 | 1989-05-11 | ホイツトセツト,ジエフリー エイ. | 肺胞疎水性界面活性物質関連タンパク質 |
IT1203873B (it) * | 1987-04-08 | 1989-02-23 | Chiesi Farma Spa | Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e |
AU1996388A (en) * | 1987-07-01 | 1989-01-30 | Kabigen Ab | Proteins and protein compositions and their use |
US4861756A (en) * | 1988-03-08 | 1989-08-29 | Merrell Dow Pharmaceuticals Inc. | Synthetic pulmonary surfactant |
SE8803713D0 (sv) * | 1988-10-18 | 1988-10-18 | Kabigen Ab | Biologically active lipoprotein and its use |
US4993280A (en) * | 1989-07-17 | 1991-02-19 | Motorola, Inc. | Rotational control assembly |
-
1988
- 1988-10-18 SE SE19888803713A patent/SE8803713D0/sv unknown
-
1989
- 1989-10-11 EP EP89850346A patent/EP0368823B2/en not_active Expired - Lifetime
- 1989-10-11 AT AT89850346T patent/ATE84799T1/de not_active IP Right Cessation
- 1989-10-11 DE DE68904530T patent/DE68904530T3/de not_active Expired - Fee Related
- 1989-10-16 JP JP1268838A patent/JP2963923B2/ja not_active Expired - Fee Related
- 1989-10-17 CA CA002000893A patent/CA2000893C/en not_active Expired - Fee Related
- 1989-10-17 AU AU42996/89A patent/AU623180B2/en not_active Ceased
- 1989-10-18 US US07/423,346 patent/US5223481A/en not_active Expired - Lifetime
-
1993
- 1993-05-21 US US08/064,382 patent/US5455227A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU623180B2 (en) | 1992-05-07 |
DE68904530T2 (de) | 1993-07-29 |
US5223481A (en) | 1993-06-29 |
EP0368823B1 (en) | 1993-01-20 |
US5455227A (en) | 1995-10-03 |
JPH02145599A (ja) | 1990-06-05 |
AU4299689A (en) | 1990-04-26 |
ATE84799T1 (de) | 1993-02-15 |
CA2000893C (en) | 2000-08-08 |
JP2963923B2 (ja) | 1999-10-18 |
EP0368823A3 (en) | 1990-05-23 |
DE68904530T3 (de) | 1999-07-08 |
DE68904530D1 (de) | 1993-03-04 |
EP0368823A2 (en) | 1990-05-16 |
SE8803713A (sv) | 1988-10-18 |
CA2000893A1 (en) | 1990-04-18 |
EP0368823B2 (en) | 1998-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8803713D0 (sv) | Biologically active lipoprotein and its use | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
DK1201241T3 (da) | Sammensætninger indeholdende capsaicin eller capsaicinanaloge og et bedøvelsesmiddel | |
DK0725648T3 (da) | Leverspecifikke farmaceutiske aktivstoffer | |
ATE55908T1 (de) | Grenzflaechenaktives mittel und dieses enthaltende arzneimittel zur verwendung bei der behandlung des atemnotsyndroms. | |
DE3587958T2 (de) | Rekombinantes alveolares oberflächenaktives protein. | |
DK0699068T3 (da) | Reduktion af liposominducerede fysiologiske bivirkninger | |
ATE143260T1 (de) | Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen | |
DE69615984T2 (de) | Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen | |
DE68912589D1 (de) | Mittel zur verbesserung des fettabbaus und verfahren zur verwendung. | |
ATE88633T1 (de) | Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. | |
FR2513126B1 (fr) | Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain | |
ATE183651T1 (de) | Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen | |
DE69021257T2 (de) | Verwendung von IFN-gamma zur Herstellung einer pharmazeutischen Zusammensetzung für die Behandlung von ATL. | |
FI915654A0 (fi) | Somatotropiner med alterneringar i alfahelixregionen 1 och kombinationer med andra mutationer. | |
ES2092969A1 (es) | Surfactante pulmonar natural de origen porcino. | |
FR2684878B1 (fr) | Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation. | |
NZ222867A (en) | Use of epidermal growth factor to enhance iron uptake into the bloodstream and pharmaceutical compositions | |
ATE40795T1 (de) | Verwendung eines zerebral und peripher wirkenden antihypoxidotikums. |